Home›Search›Current Gene Therapy

Current Gene Therapy

Bentham Science Publishers · United Arab Emirates · Est. 1961

ISSN1875-5631

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.706

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.569

Total Worksi

1,234

Total Citationsi

35,225

2yr Mean Citednessi

3.33

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Current Gene Therapy focuses on basic research and clinical applications of gene and cell therapy for diseases. It also covers genetic enhancement, immunology, gene delivery, viral vectors, transgene, and bioinformatics.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1961

FrequencyBimonthly

StatusActive (last: 2026)

Total Publications1,234

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1875-5631

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

839

2019

1.1k

2020

798

2021

303

2022

298

2023

398

2024

196

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ2

GeneticsQ2

Genetics (clinical)Q3

Molecular BiologyQ3

Molecular MedicineQ3

Subject Classification

Web of Science Categories

Genetics & Heredity

Scopus Categories

GeneticsDrug DiscoveryGenetics (clinical)Molecular MedicineMolecular Biology

Research Topics (OpenAlex)

Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringViral Infectious Diseases and Gene Expression in InsectsCancer Research and TreatmentsCAR-T cell therapy researchAnimal Genetics and ReproductionPluripotent Stem Cells ResearchMicroRNA in disease regulationAdvanced biosensing and bioanalysis techniques

Frequently asked questions about Current Gene Therapy

Is Current Gene Therapy a predatory journal?

PubScope has no integrity flags on record for Current Gene Therapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Current Gene Therapy?

Current Gene Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.33.

Is Current Gene Therapy indexed in Scopus and Web of Science?

Current Gene Therapy is indexed in Web of Science, Scopus.